Zomedica upgrades manufacturing center in Plymouth, Minnesota

Zomedica Corp. has successfully completed renovations and upgrades to its manufacturing, distribution, and R&D center located in Plymouth, Minnesota, as of September 11, 2024. The enhancements include an expanded cleanroom and improved distribution facilities, which are designed to increase manufacturing capacity and streamline shipping processes for TRUFORMA cartridges. This upgrade is a response to the growing demand for the TRUFORMA product line, which utilizes advanced sensor technology for veterinary diagnostics. Larry Heaton, the CEO of Zomedica, emphasized that the new automated production equipment will significantly bolster the company's manufacturing capabilities. The state-of-the-art TRUFORMA cartridge line is now capable of producing up to one million cartridges annually, which is expected to meet the increasing market demand for these diagnostic tools. The completion of testing and validation means that customer cartridges are already being produced on this new automated line. The TRUFORMA diagnostic platform offers veterinarians precise and sensitive measurements, providing advantages over traditional diagnostic technologies. This innovation is particularly beneficial for diagnosing complex conditions in animals, such as thyroid and adrenal disorders, gastrointestinal diseases in canines, and Cushing's disease in equines. Zomedica's strategic focus on expanding its manufacturing and distribution capabilities reflects its commitment to delivering high-quality products to its customers. With a total addressable market exceeding $2 billion in the U.S., the company is well-positioned for future growth, having reported a 33% revenue increase in 2023, reaching $25 million, and maintaining a strong liquidity position as of mid-2024.